Mekinist and Folliculitis - a phase IV clinical study of FDA data

Summary:

Folliculitis is reported as a side effect among people who take Mekinist (trametinib dimethyl sulfoxide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Tafinlar, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Folliculitis when taking Mekinist. It is created by eHealthMe based on reports of 17,345 people who have side effects when taking Mekinist from the FDA, and is updated regularly.

What is Mekinist?

Mekinist has active ingredients of trametinib dimethyl sulfoxide. eHealthMe is studying from 17,350 Mekinist users. Check the latest studies of Mekinist.

What is Folliculitis?

Folliculitis (infection of hair root) is found to be associated with 688 drugs and 1,072 conditions by eHealthMe. Check the latest studies of Folliculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

17,345 people reported to have side effects when taking Mekinist.
Among them, 23 people (0.13%) have Folliculitis.

Among these 23 people:

How long have people been on Mekinist when they have Folliculitis? *

What is the gender of people who have Folliculitis when taking Mekinist? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Folliculitis when taking Mekinist? *

What are other drugs people take besides Mekinist? *

What are other side effects people have besides Folliculitis? *

Rashes (redness): 8 people, 34.78%
Malignant Neoplasm Progression (cancer tumour came back): 7 people, 30.43%
Metastases To Central Nervous System (cancer spreads to central nervous system): 6 people, 26.09%
Fever: 5 people, 21.74%
Diarrhea: 4 people, 17.39%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 17.39%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 17.39%
Itching: 4 people, 17.39%
Dizziness: 4 people, 17.39%
Upper Respiratory Tract Infection: 4 people, 17.39%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 7 people, 30.43%
Neoplasm Malignant (cancer tumour): 5 people, 21.74%
Malignant Melanoma Stage Iv (the cancer has spread to other places in the body, such as the lung, liver, brain, bone, soft tissue, or gastrointestinal (gi) tract. cancer may have spread to places in the skin far away from where it first started): 3 people, 13.04%
Glioma (a type of tumour that starts in the brain or spine): 2 people, 8.70%
Thyroid Neoplasm (tumour of thyroid): 1 person, 4.35%
Ovarian Cancer (cancer of ovary): 1 person, 4.35%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 4.35%
Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 1 person, 4.35%
Anaplastic Thyroid Cancer (thyroid cancer which has a very poor prognosis): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Mekinist and have Folliculitis?

- Check whether Folliculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mekinist:

Mekinist (17,350 reports)

Folliculitis treatments and more:

Folliculitis (10,844 reports)

Browse all side effects of Mekinist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Folliculitis:

Folliculitis (688 drugs)

Browse all the conditions that are associated with Folliculitis:

Folliculitis (1,072 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trametinib dimethyl sulfoxide (the active ingredients of Mekinist) and Mekinist (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.